Histogram Analysis of Intravoxel Incoherent Motion for Differentiating Recurrent Tumor from Treatment Effect in Patients with Glioblastoma: Initial Clinical Experience

REFERENCES

1. 1.↵
   1. Barajas RF,
   2. Chang JS,
   3. Segal MR,
   4. et al

   . Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology 2009;253:486–96

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Hu LS,
   2. Baxter LC,
   3. Smith KA,
   4. et al

   . Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements. AJNR Am J Neuroradiol 2009;30:552–58

   Abstract/FREE Full Text
3. 3.↵
   1. Le Bihan D,
   2. Breton E,
   3. Lallemand D,
   4. et al

   . MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 1986;161:401–07

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Le Bihan D,
   2. Breton E,
   3. Lallemand D,
   4. et al

   . Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988;168:497–505

   PubMedWeb of Science
5. 5.↵
   1. Tihan T,
   2. Barletta J,
   3. Parney I,
   4. et al

   . Prognostic value of detecting recurrent glioblastoma multiforme in surgical specimens from patients after radiotherapy: should pathology evaluation alter treatment decisions? Hum Pathol 2006;37:272–82

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Le Bihan D,
   2. Turner R,
   3. MacFall JR

   . Effects of intravoxel incoherent motions (IVIM) in steady-state free precession (SSFP) imaging: application to molecular diffusion imaging. Magn Reson Med 1989;10:324–37

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Dyvorne HA,
   2. Galea N,
   3. Nevers T,
   4. et al

   . Diffusion-weighted imaging of the liver with multiple b values: effect of diffusion gradient polarity and breathing acquisition on image quality and intravoxel incoherent motion parameters: a pilot study. Radiology 2012;266:920–29

   PubMed
8. 8.↵
   1. Le Bihan D

   . Intravoxel incoherent motion perfusion MR imaging: a wake-up call. Radiology 2008;249:748–52

   CrossRefPubMed
9. 9.↵
   1. Fatterpekar GM,
   2. Galheigo D,
   3. Narayana A,
   4. et al

   . Treatment-related change versus tumor recurrence in high-grade gliomas: a diagnostic conundrum: use of dynamic susceptibility contrast-enhanced (DSC) perfusion MRI. AJR Am J Roentgenol 2012;198:19–26

   CrossRefPubMed
10. 10.↵
    1. Sugahara T,
    2. Korogi Y,
    3. Tomiguchi S,
    4. et al

    . Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. AJNR Am J Neuroradiol 2000;21:901–09

    Abstract/FREE Full Text
11. 11.↵
    1. Folkman J

    . The role of angiogenesis in tumor growth. Semin Cancer Biol 1992;3:65–71

    PubMed
12. 12.↵
    1. Jain R,
    2. Gutierrez J,
    3. Narang J,
    4. et al

    . In vivo correlation of tumor blood volume and permeability with histologic and molecular angiogenic markers in gliomas. AJNR Am J Neuroradiol 2011;32:388–94

    Abstract/FREE Full Text
13. 13.↵
    1. Jain R,
    2. Narang J,
    3. Schultz L,
    4. et al

    . Permeability estimates in histopathology-proved treatment-induced necrosis using perfusion CT: can these add to other perfusion parameters in differentiating from recurrent/progressive tumors? AJNR Am J Neuroradiol 2011;32:658–63

    Abstract/FREE Full Text
14. 14.↵
    1. Provenzale JM,
    2. Mukundan S,
    3. Barboriak DP

    . Diffusion-weighted and perfusion MR imaging for brain tumor characterization and assessment of treatment response. Radiology 2006;239:632–49

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Al Sayyari A,
    2. Buckley R,
    3. McHenery C,
    4. et al

    . Distinguishing recurrent primary brain tumor from radiation injury: a preliminary study using a susceptibility-weighted MR imaging-guided apparent diffusion coefficient analysis strategy. AJNR Am J Neuroradiol 2010;31:1049–54

    Abstract/FREE Full Text
16. 16.↵
    1. Yamada I,
    2. Aung W,
    3. Himeno Y,
    4. et al

    . Diffusion coefficients in abdominal organs and hepatic lesions: evaluation with intravoxel incoherent motion echo-planar MR imaging. Radiology 1999;210:617–23

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Federau C,
    2. Maeder P,
    3. O'Brien K,
    4. et al

    . Quantitative measurement of brain perfusion with intravoxel incoherent motion MR imaging. Radiology 2012;265:874–81

    CrossRefPubMed
18. 18.↵
    1. Prince MR,
    2. Zhang HL,
    3. Roditi GH,
    4. et al

    . Risk factors for NSF: a literature review. J Magn Reson Imaging 2009;30:1298–308

    CrossRefPubMedWeb of Science